Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to give their written agreement to take part in the study.
- People who have pulmonary arterial hypertension (a type of high blood pressure affecting the lungs) that is not considered low-risk, and who have not yet started any treatment for this condition.
Who may not be able to join:
- People with idiopathic, hereditary, or drug-related pulmonary arterial hypertension whose blood vessels responded positively to a specific test used to check how the lungs react to certain medicines (confirm with trial site).
- People who have a particular condition where the small veins or tiny blood vessels in the lungs are affected, known as pulmonary veno-occlusive disease or pulmonary capillary hemangiomatosis.
- People who are pregnant or currently breastfeeding.
- People who have a mental illness or difficulties with memory and thinking.
- People who have pulmonary arterial hypertension and also have an active cancer diagnosis.
- People who have moderate to severe liver problems, kidney problems, or severe anaemia (very low red blood cell levels).
- People who are currently taking part in another clinical trial that involves a treatment or intervention.
- People whose medical records are incomplete, or where the trial doctor has determined there are other reasons that make participation unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18553136966
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pulmonary Vascular Resistance (PVR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.